MS & LC/MS
Bruker received FDA 510(k) in April clearance for library and methods expansion for the MALDI Biotyper CA System, adding 170 species and species groups.
Waters announced in April clearance by the Chinese FDA of its ACQUITY UPLC I-Class IVD/Xevo TQ-S IVD System for IVD use in China.
Agena Bioscience named Bioyong Technology as its fifth certified service provider for China.
In May, 908 Devices closed an $11.6 million Series C funding round, bringing its funding total to $27.6 million. The round was led by Saudi Aramco.
Agilent Technologies presented Jules Griffin, who directs research into lipid profiling and signaling at the Department of Biochemistry, University of Cambridge and the Medical Research Council’s Human Nutrition Research unit, with an Agilent Thought Leader Award.
SCIEX signed a memorandum of understanding with the National University of Singapore Faculty of Science’s Protein and Proteomics Center to promote joint R&D activities in oncology biomarker discovery and development.
SCIEX and Hepregen announced a comarketing agreement to deliver a complete in vitro metabolite identification, profiling and stability solution.
SCIEX now offers New Objective’s Digital PicoView 450 Source, a nanospray ionization source.
Proteome Sciences sales of Tandem Mass Tag products increased 31% in 2014.
Bruker released in March the TASQ (Target Analysis for Screening and Quantification) 1.0 software for its Q-TOF MS systems for screening for trace residues in complex matrices. It also debuted Pacer 2.0 software for high-throughput targeted analyses in the routine lab using Bruker GC and LC triple quadrupole MS systems.
SCIEX launched its Custom Method Development and Consulting program for complex biotherapeutics. It is initially available in the Americas.
In April, Bruker introduced the MALDI Biotypersmart, a high-throughput option with increased laser lifetime and higher laser repetition rate. It is IVD-CE marked.
Bruker introduced the IVD MALDI Sepsityper kit and workflow with SOPs for the rapid identification of microorganisms from positive blood culture bottles. It is IVD-CE labeled.
In April, Agilent Technologies launched the midrange 6545 Q-TOF MS system, featuring improved sensitivity for routine analyses and robustness.
GlycoScientific introduced the iGlycoMab, a mAb whose glycans are labeled with a stable isotope designed to facilitate quantitative glycan profiling.
IonSense released the DART-OS open-air ionization source for Waters’s ACQUITY QDa Mass Detector.